EUVIMEDEUVIMED entdecken
Crossref

Development of Low-Density Lipoprotein Receptor-Targeted Liposomes for Enhanced Accumulation in Ischemia/Reperfusion Environment

Shintaro Yoneda, Kentaro Kogure

Biological and Pharmaceutical Bulletin · 2025

DOI: 10.1248/bpb.b25-00118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2025. Verfasst von Shintaro Yoneda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Health Chemistry, Graduate School of Pharmaceutical Sciences, Tokushima University, 1-78-1 Shomachi, Tokushima 770-8505,…. Hauptthemen laut MEDLINE: Reperfusion Injury, Receptors, LDL. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral ischemia/reperfusion (I/R) injury caused by resumed blood flow to an infarcted area contributes to poor patient prognosis due to a lack of treatment strategies. While the blood-brain barrier (BBB) is the greatest barrier for drug delivery to the brain, temporary disruption to the BBB after brain I/R injury allows for delivery of cerebroprotective drug-encapsulated nanoparticles into the brain parenchyma. However, issues remain with delivering drugs to the I/R region using nanoparticles, such as the limited therapeutic time window due to BBB repair over time. To overcome these challenges, we developed nanoparticles specifically targeting the I/R environment. Human umbilical vein endothelial cells (HUVECs) were exposed to oxygen-glucose deprivation/reoxygenation (OGD/R), an in vitro I/R model. Low-density lipoprotein receptor (LDLR) mRNA was upregulated early during the reoxygenation process. Furthermore, immunostaining of OGD/R-treated cells showed an increase in LDLR expression. Next, we constructed a peptide that mimics the LDLR binding recognition site on LDL, and modified liposomes to display the peptide on their surface. Peptide-modified liposomes showed targeting ability to the LDLR on cells. Accumulation of peptide-modified liposomes was significantly increased in OGD/R treated cells compared with controls, and was reduced by blocking LDLR using its antibody. These results demonstrate upregulation of LDLR and LDLR-mediated liposome uptake in OGD/R stressed cells. In conclusion, LDLR binding recognition site mimicking peptide-modified liposomes are a useful drug carrier that can recognize I/R injured endothelial cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryReceptors, LDLHumansLiposomesHuman Umbilical Vein Endothelial CellsPeptidesGlucoseDrug Delivery SystemsNanoparticlesBlood-Brain BarrierOxygen

Stichwörter der Autor:innen

cerebral ischemia/reperfusion injuryendothelial cellliposomelow-density lipoprotein receptoroxygen-glucose deprivation/reoxygenationtargeting peptide

Substanzen

LiposomesReceptors, LDLPeptidesGlucoseOxygen

Autor:innen und Institutionen

  • Department of Pharmaceutical Health Chemistry, Graduate School of Pharmaceutical Sciences, Tokushima University, 1-78-1 Shomachi, Tokushima 770-8505, Japan.
  • Department of Pharmaceutical Health Chemistry, Graduate School of Biomedical Sciences, Tokushima University, 1-78-1 Shomachi, Tokushima 770-8505, Japan.
  • Research Center for Innovative Drug Delivery System, Graduate School of Biomedical Sciences, Tokushima University, 1-78-1 Shomachi, Tokushima 770-8505, Japan.

Zitieren

APA

Yoneda, S., & Kogure, K. (2025). Development of Low-Density Lipoprotein Receptor-Targeted Liposomes for Enhanced Accumulation in Ischemia/Reperfusion Environment. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b25-00118

Vancouver

Yoneda S, Kogure K. Development of Low-Density Lipoprotein Receptor-Targeted Liposomes for Enhanced Accumulation in Ischemia/Reperfusion Environment. Biological and Pharmaceutical Bulletin. 2025. doi:10.1248/bpb.b25-00118

BibTeX
@article{Yoneda2025,
  author = {Yoneda, Shintaro and Kogure, Kentaro},
  title = {Development of Low-Density Lipoprotein Receptor-Targeted Liposomes for Enhanced Accumulation in Ischemia/Reperfusion Environment},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2025},
  doi = {10.1248/bpb.b25-00118}
}
Kostenlos starten →